Today's Datapoint
$18
billion is
the projected total of patent expirations for brand-name pharmaceuticals in
2014, with $21 billion projected for 2015 and $22 billion in 2016, according to
Chris Peterson, Pharm.D., a director in the Emerging Therapeutics department at
Express Scripts Holding Company.
No comments:
Post a Comment